Synlogic Inc (SYBX)
1.65
-0.03
(-1.79%)
USD |
NASDAQ |
May 20, 14:24
Synlogic Enterprise Value: -28.53M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -28.53M |
| May 16, 2024 | -28.18M |
| May 15, 2024 | -27.71M |
| May 14, 2024 | -27.36M |
| May 13, 2024 | -26.78M |
| May 10, 2024 | -26.90M |
| May 09, 2024 | -26.43M |
| May 08, 2024 | -26.49M |
| May 07, 2024 | -26.32M |
| May 06, 2024 | -26.32M |
| May 03, 2024 | -26.32M |
| May 02, 2024 | -25.85M |
| May 01, 2024 | -25.62M |
| April 30, 2024 | -26.90M |
| April 29, 2024 | -25.97M |
| April 26, 2024 | -25.97M |
| April 25, 2024 | -26.08M |
| April 24, 2024 | -25.97M |
| April 23, 2024 | -25.50M |
| April 22, 2024 | -26.32M |
| April 19, 2024 | -25.97M |
| April 18, 2024 | -26.43M |
| April 17, 2024 | -27.13M |
| April 16, 2024 | -26.78M |
| April 15, 2024 | -26.78M |
| Date | Value |
|---|---|
| April 12, 2024 | -27.13M |
| April 11, 2024 | -27.36M |
| April 10, 2024 | -26.55M |
| April 09, 2024 | -26.43M |
| April 08, 2024 | -27.48M |
| April 05, 2024 | -27.01M |
| April 04, 2024 | -26.90M |
| April 03, 2024 | -26.90M |
| April 02, 2024 | -27.25M |
| April 01, 2024 | -27.25M |
| March 28, 2024 | -26.90M |
| March 27, 2024 | -27.01M |
| March 26, 2024 | -27.01M |
| March 25, 2024 | -26.78M |
| March 22, 2024 | -26.78M |
| March 21, 2024 | -27.36M |
| March 20, 2024 | -27.60M |
| March 19, 2024 | -27.01M |
| March 18, 2024 | -25.62M |
| March 15, 2024 | -26.20M |
| March 14, 2024 | -27.25M |
| March 13, 2024 | -26.08M |
| March 12, 2024 | -25.85M |
| March 11, 2024 | -30.75M |
| March 08, 2024 | -30.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-74.74M
Minimum
Mar 12 2020
190.96M
Maximum
Jun 17 2019
-3.820M
Average
-20.19M
Median
May 25 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.53M |
| Revenue (Quarterly) | 2.769M |
| Total Expenses (Quarterly) | 13.41M |
| EPS Diluted (Quarterly) | -1.582 |
| Profit Margin (Quarterly) | -524.9% |
| Earnings Yield | -651.6% |
| Normalized Earnings Yield | -651.65 |